|
|
40
|
|
|
A322KR
|
|
|
VENLAFAXINE ER 150MG CAP (APL/AHI) VENLAFAXIN
|
|
|
VENLAFAXINE
|
|
|
VENLAFAXINE ER
|
|
|
90'S
|
|
|
BP
|
|
|
69.43
|
|
|
0.77
|
|
|
150MG
|
|
|
CAPSULE
|
|
|
0
|
|
|
CAP
|
|
|
APL
|
|
|
AUROBINDO PHARMA LTD.
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
28160416
|
|
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
|
|
|
|
|
Oral
|
|
|
6
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|